From a clinical perspective, screening patients with the combination of cerebellar ataxia (the initial presenting complaint) and SG in the absence of any other cause has a diagnostic yield of 71% for RFC1 expansion. The gene discussed is RFC1; the disease is aceruloplasminemia.